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Abstract: 
Leishmaniasis is a protozoal disease of human that occurs in most parts of the world. By considering the progress of 
bioinformatics in molecular modeling, major surface glycoprotein of Leishmania donovani (gp63) structure was modeled 
using homology modeling with high accuracy based on the X-ray crystal structure of the Leishmania major gp63 as a 
template, and then analyzed 3D structure of gp63 which can reveal exact facts about its structure and interaction. The 
objective of this study was to find folding and three dimensional structure of the gp63 as potent antigen for human. In this 
project, we applied the theory of evolution method, including comparative modeling and threading. This study presented a 
simple protocol for rapid and precise finding 3D structure of gp63 and investigation of its structural properties. The 
translated amino acid sequence showed that Leishmania donovani gp63 contains 590 amino acids precursor protein 
consisting of an NH2-terminal signal peptide of 39 amino acids for membrane targeting, a pro region of 48 amino acids, the 
mature protein of 478 amino acids containing glycosylation and putative catalytic sites, and a COOH-terminal signal peptide 
of 25 amino acids for GPI attachment. Based on our model, the protein consists of three domains: the N-terminal, central and 
C-terminal domains. Additionally, these results could guide future structure-function analyses of gp63 protein. 
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Background: 
Leishmaniasis is a parasitic disease that caused by infection 
with species of Leishmania and occurs in most parts of the 
world. Visceral leishmaniasis (VL) is caused by 
Leishmania donovani and motivates large-scale epidemics 
with a high fatality rate. [1] Leishmania species possess a 
membrane glycoprotein on their surface which is called 
leishmanolysin. This major surface glycoprotein of 
Leishmania, referred to as gp63, is a zinc metalloproteinase 
of 63,000 Daltons containing a glycosyl phosphatidyl 
inositole (GPI) membrane anchor, which is displayed 
abundantly on the surface of promastigotes (~5×10
5 
molecules/cell), however in a less density on the surface of 
amastigotes. [2] gp63 has been shown to function in the 
receptor mediated uptake of promastigotes by macrophages 
in the mammalian host. [3] It is one of the parasite 
receptors for host macrophages, and parasite mutants 
lacking the protein are non-virulent. [4] gp63 facilitates 
survival of the extracellular promastigote stage in the 
presence of host complement, likely by converting 
complement component C3b to C3bi. It also promotes 
attachment of promastigotes to macrophage receptors such 
as CR3, the receptor for C3bi. [5] There is evidence that 
gp63 promotes amastigote survival within macrophage 
phagolysosomes. gp63 protects parasite from lysosomal 
cytolysis and degradative activities of macrophage by its 
protease activity. [6] It can also protect liposome-
encapsulated proteins from phagolysosomal degradation by 
macrophages.  [7] Thus, gp63 plays a crucial role in 
macrophage binding to Leishmania and in intramacrophage 
survival and replication. [8] gp63 is a neutral site-specific 
endopeptidase cleaving a variety of substrates, [9] such as 
clusters of differentiation (CD) 4 molecules on human T 
cells. [10] It is synthesized as an inactive precursor, which 
is activated via a cysteine switch mechanism [11] and has 
been reported to hydrolyze a variety of substrates including 
casein, azocasein, gelatin, albumin, hemoglobin and 
fibrinogen. [12] gp63 shares several characteristics with the 
members of the matrix metalloproteinase family including 
degradation of components of the extracellular matrix such 
as fibrinogen, location at the cell surface, requirement for 
Zn
2+ and sequence similarity of the proposed active site, 
inhibition of the proteinase activity by chelating agents and 
α2-macroglobulin,  [13] secretion as a latent form of the 
enzyme and the activation by mercurial compounds. [14] 
gp63 is one of the promising candidates for subunit vaccine 
against leishmaniasis. As the three-dimensional structure of 
Leishmania donovani gp63 was not available, no 
correlations could have been made between the 3D 
structure and function of its protection as vaccine. By 
considering the progress of bioinformatics in molecular 
modeling, we can model gp63 structure using homology 
modeling with high accuracy, and then analyze 3D 
structure of gp63 which can reveal exact facts about its 
structure, interaction and function. 
 
Methodology: 
Searching databases to find right sequences 
Target protein was searched by name in the Swiss-Prot and 
TrEMBL databases through ExPASy server to find raw 
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Leishmania donovani, gives rise to large-scale epidemics 
with a high fatality rate and its treatment is a serious 
problem and is also widely endemic in Iran. [1] Therefore, 
among 452 sequences for gp63 in Swiss-Prot and TrEMBL 
databases, the sequence of Leishmania donovani gp63 was 
selected from Swiss-Prot database. 
 
Comparative modeling 
The process of comparative protein structure modeling 
usually requires the use of many programs, to identify 
template structure, generate sequence-structure alignments, 
build and evaluate models. Our results can be divided into 
four categories: 1) Initial construction of comparative 
model was achieved by MODELLER and MOE. 2) 
Refinement of comparative models was facilitated by 
MODELLER, MOE and Swiss-PdbViewer. 3) Inspection 
and analysis of models was made by ERRAT, VERIFY3D, 
PROCHECK and WHAT IF. 4) The models were got 
better when template selection, target-template alignment 
and model building were improved.  
 
Finding structures and sequences related to the target 
sequence 
Before any modeling can begin, the sequences and 
segments with known 3D structures that are related to the 
sequence being modeled must be found. This was achieved 
by searching a database of structures that are representative 
structures of the whole Protein Data Bank (PDB), using 
BLAST programs through different servers. The similarity 
search was performed at the SIB by the BLAST network 
service using NCBI-BLAST 2 program under BLOSUM62 
comparison matrix. The similarity search was also carried 
out through EBI and NCBI servers and the results were 
quite similar. Another method to find template is fold 
assignment or threading. It was achieved through FUGUE 
and 3D-PSSM web servers. 
 
Template selection 
Several factors need to be taken into account when 
selecting a template. The quality of a model increases with 
overall sequence similarity of template to the target and 
decreases with the number and length of gaps in the 
alignment. The simplest template selection rule is to select 
the structure with the highest sequence similarity to the 
target sequence. Another important parameter is the length 
of the template. Therefore, it is necessary to consider 
family, identity and the number of residues participating in 
the alignment in order to select the best template. CATH 
and SCOP databases were used to find the related super 
family of target protein. At the super family level, proteins 
probably share an evolutionary relationship, even if they 
share relatively low amino acid sequence identity in pair 
wise alignments. Thus, the selected templates must be 
assigned based on classification. The best result for 
alignment of gp63 sequence against PDB entries through 
ExPASy server was obtained. 
 
Alignment of the target sequence and template 
3D structure solution does not always end up with full 
length structure due to the complexity of some regions in 
X-ray diffraction map. To avoid mismatching between the 
number of the residues in the sequence and the PDB file, 
we derived the sequence directly from the related PDB file 
through Swiss-PdbViewer not the databases such as 
SwissProt and TrEMBL. Although MODELLER could do 
sequence and structure alignment, the alignments were also 
carefully prepared by other resources such as ClustalX, T-
COFFEE, CPHmodels, ESyPred3D, FUGUE and 3D-
PSSM. These diverse alignments with different gap regions 
created various models that had different ERRAT and 
VERIFY3D scores. 
 
Evaluating the models 
After building the models, they checked for possible errors 
and determined whether or not were acceptable. Initial 
models were subjected to detailed evaluation, mainly by 
visual inspection of structural consistency in Swiss-
PdbViewer and ViewerLite, secondary structure matching 
with the secondary structure prediction and using ERRAT 
program. Two types of evaluation were accomplished: 
stereo chemical quality and side chain environment. 
PROCHECK was utilized to assess the quality of the 
conformation of the polypeptide backbone and side chains 
using a Ramachandran plot. The steric overlap of atoms 
(bad clashes) was checked using bump check within 
WHAT IF, and selection of ‘aa Making Clashes’ command 
in Swiss-PdbViewer program. 
 
VERIFY3D and ERRAT were used to evaluate the 
compatibility between the amino acid sequence and the 
environment of the amino acid side chains in the model. 
The result of ERRAT program was the main assignment 
factor for investigating of the progress in comparative 
modeling of target protein. Also, there were reasonable 
agreement between the position of helices and sheets in 
each generated model and those in the secondary structure 
prediction by Jpred server. This agreement confirmed the 
accuracy of modeling procedure for target protein. 
 
Model regeneration and refinement 
In the case of unsuccessful models (bad points and scores 
in evaluation), we stepped backward and realigned or 
regenerated models sometimes using totally different 
alignment or template till an acceptable model was created. 
To clarify the affect of alignment in refining a model an 
example is given here. For instance, only with the 
following change in the pairwise alignment of gp63, 
ERRAT percentage rise from 85.043 to 91.649 presenting 
huge improvement in model quality. 
 
Discussion: 
Overall structure 
Gp63 is a compact molecule containing predominantly β 
sheet secondary structure. This is against of the other 
protozoan surface antigen structures determined to date. 
[15] The physico-chemical properties of gp63 calculated 
by ProtParam (an online tool on the ExPASy server) 
showed that the exact molecular weight was 62950.3 
Dalton, isoelectric point (pI) = 6.41 and the total charge 
was -5. The three-dimensional structure of gp63 protein 
was modeled using comparative modeling of this protein 
based on the X-ray crystal structure of the Leishmania 
major  gp63 (PDB code: 1LML) as a template. The 
alignment of target sequence and template showed 81% 
sequence identity. According to data in Ramachandran plot 
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regions was above 84%. Consequently, this result 
suggested the proper geometry for model. Because the 
model optimized and refined by MODELLER, it had no 
bump (bad clashes). Furthermore, the result of ERRAT 
program (overall quality factor = 91.649) showed the gp63 
model had acceptable side chain environment. Also, the 
Accessible Surface Area (ASA) of gp63 model, calculated 
by RVP-NET program, indicated agreement between the 
model and the results (Figure 1a). The translated amino 
acid sequence shows that Leishmania donovani gp63 
contains 590 amino acids precursor protein consisting of an 
NH2-terminal signal peptide of 39 amino acids for 
membrane targeting, a pro region of 48 amino acids, the 
mature protein of 478 amino acids containing glycosylation 
and putative catalytic sites, and a COOH-terminal signal 
peptide of 25 amino acids for GPI attachment [16] (Figure 
1a). The protein consists of three domains: the N-terminal, 
central and C-terminal domains (Figure 1b).  
 
 
Figure 1: a) Three-dimensional structure of gp63 model based on 1LML, 1CM5, 1TZC and 1HGV. α-helices and β-sheets 
are in red and blue respectively. Green color represents loop while the grey areas are turns. Zinc atom is shown as a yellow 
sphere. ASA calculation for Glu46 was 48.4 which indicate to surfaced exposed amino acid. b) 3D structure of gp63 
domains. c) The N-terminal domain of gp63 model. Pink ribbon represents the 35-residue flap while the yellow ribbon 
shows 38-residue flap. Dark yellow stick style indicates disulfide bond. d) The central domain of gp63 model. Orange ribbon 
represents the met-turn. e) The active site of gp63 model. His251, Glu252, His255 and His321 are within 4 Å radius of the 
zinc atom. The residues are shown as stick display style and zinc atom as yellow sphere. f) The C-terminal domain of gp63 
model. 
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N-terminal domain 
The N-terminal domain includes Val87-Ser260 of the 
model and has a fold similar to that of the catalytic 
modules of zinc proteinases. [17] This domain contains a 
catalytic zinc atom and an active site helix containing the 
two histidines of the zinc proteinase sequence motif 
HEXXH (His-Glu-Xaa-Xaa-His). There are deep surface 
indentations at domain interfaces that join the active site 
cleft, which is located between the N-terminal domain and 
the central domain of the molecule. [15] Three-dimensional 
structures of zinc proteinases containing the HEXXH 
sequence motif have been grouped into two families: the 
bacterial thermolysins and the metzincins. [18] Molecules 
of both classes have a major catalytic domain with a 
topology consisting of two α-helices (A and B) packed 
against one side of a five-stranded twisted β  sheet. The 
HEXXH motif is located on helix B and the two histidine 
side chains are ligands of the zinc atom active site. The N-
terminal domain of gp63 includes 35- and 38-residue 
inserted ‘flaps’ which cover the side of the β sheet opposite 
of the helices (Figure 1c). The 38-residue flap replaces the 
second strand of the central sheet in the conserved 
topology. [15] There are two disulfide bonds within this 
domain, one between residues Cys112-Cys129 and the 
other is between residues Cys178-Cys217 (Figure 1c). 
 
Central domain 
Residues Val261-Glu378 of gp63 folds into a compact 
domain with antiparallel helices. A single disulfide bond 
(residues Cys301-Cys373) connects the C terminus of the 
domain to the beginning of the long loop (Figure 1d). 
Metzincin class zinc proteinases have an extended zinc 
proteinase motif HExxHxxGxxH, where the glycine 
residue is part of a tight turn at the end of active site helix 
B, allowing the extra histidine of the motif to form the third 
ligand of the zinc atom active site. Metzincins share two 
additional structural features, an unusual tight 1,4 ‘met-
turn’ with a conserved methionine at the base of the active 
site, and a following helix (helix C), which is roughly 
parallel to the active site helix B. The central domain of 
gp63 contains a corresponding met-turn (Asp329-Ala335) 
(Figure 1d) and a helix C, but there is an unexpected 62 
amino acids insertion between the glycine and third 
histidine residue (Gly258-His321) of the metzincin motif 
that represents half of the central domain. gp63 is clearly a 
metzincin class zinc proteinase, but does not satisfy the 
defining sequence motif HExxHxxGxxH because of the 
insertion between the glycine (Gly258) and the last 
histidine (His321). 
 
The active site 
To find likely residues involved in the active site, residues 
within a 4 Angstrom radius of the zinc atom were selected 
using Swiss-PdbViewer program because the zinc atom has 
already been identified as a major part of the active site. 
[15] The zinc atom is coordinated to the nitrogen atoms of 
His251, His255 and His321. The gp63 zinc active site 
appears to be tetra coordinated, with Glu252 (Figure 1e). 
 
C-terminal domain 
The elongated C-terminal domain (residues Lys379-
Asn565) of gp63 consists of mainly antiparallel β strand 
and random coil structure with only minor helical 
contributions. The domain contains six disulfide bonds 
(Cys380-Cys443, Cys393-Cys412, Cys402-Cys477, 
Cys454-Cys498, Cys503-Cys553 and Cys523-Cys546) 
(Figure 1f). The N-terminal part of the domain also 
contains three two-stranded antiparallel sheets. These 
sheets are connected via two short helices to an antiparallel 
six-stranded β sheet folded into a sandwich structure and 
this is in turn attached via two short helices to the GPI 
anchor. [15] 
 
Conclusion: 
Although there is no evidence for similar antigenic 
variation in Leishmania, gp63 sequences derived from 
different species do differ.  Leishmania sequences are at 
least 60% identical and the mature proteins share all 18 
cysteines, the active site zinc ligand and methionine turn 
residues with the less conserved gp63 homologues from 
Crithidia and Trypanosoma brucei. The Leishmania 
donovani  carbohydrate-linked residue (Asn287) and the 
GPI anchor attachment site at Asn565 are not conserved in 
Leishmania species. As expected, surface residues are less 
conserved than interior residues, and a surface 
representation of variability suggests sequence variability 
is correlated with structural flexibility. In summary, this 
work provides evidence that the homology modeling 
approach based on a reliable template could result in 
accurate and precise structural models that bear significant 
quality for finding crucial residues which affect protein 
structure, interaction and function. 
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